University of Cambridge invites applications for a four-year PhD studentship starting 1 October 2027. The project is a collaboration between the Department of Pathology (University of Cambridge) and the AstraZeneca Discovery Centre, with joint supervision from Prof. Andrew Firth and Dr Giovanni Ciotta.
Work across both sites to probe peptide-bond skipping for protein engineering. The project emphasises molecular biology, ribosome profiling, and potential bioinformatics and structural biology
#J-18808-Ljbffr
PhD: Optimizing 2A Peptides for Polyprotein Split in Cambridge employer: University of Cambridge
The University of Cambridge offers a dynamic and collaborative work environment, particularly within the Department of Oncology, where you will play a pivotal role in advancing cancer research. With a strong emphasis on employee growth, you will have access to professional development opportunities and the chance to work alongside leading experts in the field. The university's commitment to innovation and excellence ensures that your contributions will have a meaningful impact on clinical care and research outcomes.
